CIBC Capital Markets raised its price target on WELL Health Technologies Corp. (WELL.TO) to $5.25 from $5.
Analyst Scott Fletcher maintained a Neutral rating on shares of the Vancouver-based digital health technology and outpatient clinic company.
"WELL provided an update on its Canadian clinical business, as it continues to acquire additional clinics and drive cost savings in the clinical business," Fletcher said in a note to clients.
"Of WELL's portfolio, we remain most interested in WELL's Canadian assets, both on the clinical and digital side," the analyst said.
"US asset sales, and the clarity they would bring to the story, are the likely next catalyst for WELL, but timing of sales remains uncertain given the accounting issues at Circle Medical and the lack of viable offers for WISP received to date."
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。